| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,048 |
20,988 |
$2.08M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,087 |
12,382 |
$2.02M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,653 |
1,148 |
$276K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,341 |
4,861 |
$248K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,100 |
1,042 |
$92K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,197 |
1,051 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,252 |
11,882 |
$32K |
| 80053 |
Comprehensive metabolic panel |
10,861 |
9,788 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,427 |
1,248 |
$29K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,353 |
1,162 |
$22K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
765 |
663 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
653 |
566 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
291 |
253 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
16 |
12 |
$7K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
919 |
805 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
197 |
173 |
$6K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
536 |
495 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
5,028 |
4,483 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
478 |
435 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,753 |
1,656 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
182 |
160 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,636 |
1,542 |
$3K |
| 81001 |
|
2,406 |
2,164 |
$3K |
| 80061 |
Lipid panel |
1,248 |
1,166 |
$2K |
| 83690 |
|
611 |
544 |
$2K |
| 84484 |
|
430 |
374 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
411 |
359 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
260 |
116 |
$927.20 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
26 |
$738.81 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
166 |
142 |
$536.48 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
82 |
77 |
$453.12 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
34 |
29 |
$335.30 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
335 |
302 |
$276.47 |
| 83605 |
|
190 |
171 |
$264.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
80 |
50 |
$237.01 |
| J2704 |
Injection, propofol, 10 mg |
122 |
81 |
$169.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
351 |
311 |
$145.71 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
307 |
251 |
$130.01 |
| 87186 |
|
79 |
76 |
$118.69 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
121 |
111 |
$110.25 |
| 83880 |
|
16 |
14 |
$109.92 |
| 87077 |
|
103 |
100 |
$106.91 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
19 |
18 |
$91.55 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
110 |
103 |
$83.07 |
| 83735 |
|
16 |
12 |
$77.38 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
50 |
49 |
$73.58 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
101 |
95 |
$51.29 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
101 |
95 |
$51.29 |
| 87276 |
|
205 |
198 |
$45.92 |
| 87275 |
|
205 |
198 |
$41.38 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$28.70 |
| 84466 |
|
13 |
13 |
$22.03 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
41 |
29 |
$20.98 |
| 86803 |
|
30 |
29 |
$19.98 |
| 84703 |
|
89 |
85 |
$18.32 |
| 83540 |
|
13 |
13 |
$17.67 |
| 81025 |
|
115 |
107 |
$16.94 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16 |
16 |
$16.86 |
| 84439 |
|
140 |
132 |
$14.01 |
| 87088 |
|
129 |
117 |
$5.17 |
| 85610 |
|
26 |
24 |
$3.84 |
| 82962 |
|
78 |
70 |
$3.47 |
| 87210 |
|
33 |
29 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
18 |
13 |
$0.00 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
22 |
16 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
21 |
17 |
$0.00 |
| 87807 |
|
69 |
68 |
$0.00 |
| 85027 |
|
17 |
14 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
29 |
28 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
21 |
15 |
$0.00 |
| 85379 |
|
12 |
12 |
$0.00 |
| 87430 |
|
12 |
12 |
$0.00 |
| 85652 |
|
42 |
39 |
$0.00 |
| 87081 |
|
26 |
26 |
$0.00 |
| 82043 |
|
15 |
15 |
$0.00 |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
31 |
12 |
$0.00 |
| 86140 |
|
14 |
12 |
$0.00 |